What is the appropriate next step in management for a 50-year-old male who, after heat stroke, presents with persistent symptomatic bradycardia (average heart rate 52 bpm, nadir 29 bpm) and a 14 % pacing burden on two‑week ambulatory monitoring?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management Recommendation

This patient requires evaluation for permanent pacemaker implantation given persistent symptomatic bradycardia with a heart rate nadir of 29 bpm occurring 3 days after heat stroke, indicating this is likely not a reversible cause but rather unmasked or heat-induced sinoatrial node dysfunction. 1

Clinical Reasoning

Heat Stroke as a Reversible Cause

The 2018 ACC/AHA/HRS Bradycardia Guidelines explicitly state that patients with symptomatic sinus node dysfunction (SND) secondary to a reversible cause should first be managed by eliminating or mitigating the offending condition 1. Heat stroke can cause transient sinoatrial node dysfunction 2, and one case report demonstrated complete resolution of sinoatrial dysfunction with aggressive cooling in the emergency department 2.

However, this patient presented 3 days after the heat stroke event and has now completed 2 weeks of monitoring while still demonstrating severe bradycardia. This timeline strongly suggests the heat stroke either:

  • Unmasked pre-existing SND
  • Caused permanent sinoatrial node damage
  • Is no longer the active reversible cause

Key Decision Points

The critical factors favoring pacemaker consideration are:

Symptomatic bradycardia: The patient has persistent weakness, fatigue, chest pain, and dyspnea—these are symptoms directly attributable to bradycardia 1

Severe bradycardia parameters:

  • Average heart rate of 52 bpm (borderline)
  • Nadir of 29 bpm (critically low)
  • These rates occurred during a 2-week monitoring period, not acutely during heat stroke

Temporal relationship: Three days post-heat stroke with 2 weeks of continued monitoring demonstrates this is not an acute, reversible phenomenon

Guideline Framework

The 2018 guidelines emphasize that permanent pacing for SND is indicated for symptom relief and quality of life improvement 1. The guidelines specifically note that:

  • Asymptomatic or minimally symptomatic patients have no indication for pacing even with documented SND
  • Symptomatic patients with documented bradycardia benefit from pacing
  • Pacing should be avoided when symptoms occur in the absence of documented bradycardia

This patient clearly has symptoms temporally correlated with documented severe bradycardia (nadir 29 bpm).

The 14% PAC Burden

The 14% premature atrial contraction burden is notable but does not change the primary management decision. This could represent:

  • Concurrent atrial irritability
  • Part of a tachy-brady syndrome spectrum
  • Unrelated finding

If tachy-brady syndrome develops, this would further support pacemaker implantation, as these patients often require both antiarrhythmic medications (which would worsen bradycardia) and pacing support 1.

ATM Mutation Consideration

The ATM (ataxia-telangiectasia mutated) gene mutation is associated with increased cancer risk and radiation sensitivity but does not directly cause cardiac conduction disease. This should not alter the bradycardia management but may influence decisions about cardiac imaging modalities if needed.

Recommended Management Algorithm

  1. Confirm symptom-rhythm correlation: Review the 2-week monitor data to verify that symptoms (weakness, fatigue, chest pain, dyspnea) occurred during bradycardic episodes, particularly during the severe episodes approaching 29 bpm

  2. Rule out remaining reversible causes:

    • Thyroid function tests (hypothyroidism can cause bradycardia) 1
    • Electrolytes including potassium (hyperkalemia can worsen conduction) 2
    • Review all medications for negative chronotropic agents (beta-blockers, calcium channel blockers, digoxin, antiarrhythmics) 1
    • Consider cardiac biomarkers and echocardiogram given chest pain and heat stroke's known cardiac effects 3, 4
  3. If reversible causes are excluded and symptoms persist: Refer to electrophysiology for permanent pacemaker evaluation

  4. Pacemaker selection: If indicated, choose a physiologic pacing mode (DDD or AAI if AV conduction intact) to address both the bradycardia and allow for potential future atrial arrhythmias given the PAC burden

Critical Pitfalls to Avoid

Do not delay pacemaker evaluation waiting for "more time" to pass. Three days plus 2 weeks of monitoring is sufficient to determine this is not an acute reversible phenomenon from heat stroke 1, 2

Do not dismiss symptoms as anxiety or deconditioning. A heart rate of 29 bpm is profoundly bradycardic and will cause symptoms in virtually all patients

Do not confuse physiologic nocturnal bradycardia with pathologic daytime bradycardia. The guidelines note that rates below 40 bpm during sleep can be normal 1, but this patient's average of 52 bpm with a nadir of 29 bpm over 2 weeks suggests daytime pathology

Do not assume the PAC burden requires treatment before addressing bradycardia. The bradycardia is the immediate life-threatening issue; PACs at 14% burden are generally benign unless causing symptoms

Related Questions

What is the recommended management for a patient with symptomatic sinus bradycardia (heart rates 30–40 bpm) presenting with dizziness and fatigue?
In which of the following conditions may sinus bradycardia be observed: cholestatic jaundice, acute inferior myocardial infarction, hypothermia, gram‑negative bacterial sepsis, or all of the above?
In a hemodynamically stable patient presenting with shortness of breath, fatigue, and ECG evidence of bradycardia, what is the next step in management?
What is the appropriate outpatient evaluation and management plan for a 32-year-old woman with no past medical history who experiences episodes of sinus bradycardia with heart rates in the 30s?
In a 75-year-old man with hyperlipidemia, thyroid disease, benign prostatic hyperplasia, pre‑diabetes, and bradycardia who presents with orthostatic hypotension and dizziness and has sinus bradycardia on Holter monitoring, what is the next step in management?
What is the appropriate initial therapy for a teenager with mild asthma?
How can I differentiate a 2:1 atrioventricular (AV) block from Mobitz type II and determine the appropriate management?
How should I acutely manage a 41‑year‑old female with a history of acalculous cholecystitis who now presents with severe right‑upper‑quadrant pain, vomiting, leukocytosis, elevated inflammatory markers, high bilirubin and markedly elevated transaminases, a dilated common bile duct, possible acute cholangitis, and who is currently taking rivaroxaban?
In a 48‑year‑old woman on 75 µg levothyroxine (T4) who is asymptomatic with a TSH of 5.16 mIU/L, is it appropriate to prescribe liothyronine (T3) instead of increasing the levothyroxine dose?
How common is a mild isolated elevation of alkaline phosphatase in patients with non‑alcoholic fatty liver disease (NAFLD) when all other liver function tests are normal?
What is the trade name for prasugrel?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.